In AD patients, cutaneous S. aureus is capable of inducing myeloid-derived suppressor cells, leading to in vivo immune suppression of the T cell activation in the skin; in mice exposed to wild-type S. aureus on skin, there are reduced numbers of CD4+ and CD8+ T cells in the spleen27. Here, CD8A is linked to Alzheimer disease.